Impact of Comorbid Disease Burden on Clinical Outcomes of Female Acute Myocardial Infarction Patients
- PMID: 36794246
- PMCID: PMC9900217
- DOI: 10.4068/cmj.2023.59.1.61
Impact of Comorbid Disease Burden on Clinical Outcomes of Female Acute Myocardial Infarction Patients
Abstract
Owing to the paucity of information on the clinical outcomes in female patients with acute myocardial infarction (AMI) in relation to the comorbid disease burden, we explored the differences in their clinical outcomes and identified predictive indicators. A total of 3,419 female AMI patients were stratified into two groups: Group A (those with zero or one comorbid diseases) (n=1,983) and Group B (those with two to five comorbid diseases) (n=1,436). Five comorbid conditions were considered: hypertension, diabetes mellitus, dyslipidemia, prior coronary artery disease, and prior cerebrovascular accidents. The primary outcome was major adverse cardiac and cerebrovascular events (MACCEs). The incidence of MACCEs was higher in Group B than in Group A in both the unadjusted and propensity score-matched data. Among the comorbid conditions, hypertension, diabetes mellitus, and prior coronary artery disease were found to be independently associated with an increased incidence of MACCEs. Higher comorbid disease burden was positively associated with adverse outcomes in the female population with AMI. Since both hypertension and diabetes mellitus are modifiable and independent predictors of adverse outcomes after AMI, it may be necessary to focus on the optimal management of blood pressure and glucose levels to improve cardiovascular outcomes.
Keywords: Female; Multimorbidity; Myocardial infarction; Treatment outcome.
© Chonnam Medical Journal, 2023.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT: None declared.
Figures



Similar articles
-
Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.Cardiovasc Diabetol. 2021 Feb 11;20(1):43. doi: 10.1186/s12933-021-01236-3. Cardiovasc Diabetol. 2021. PMID: 33573649 Free PMC article.
-
Prognostic Value of Serum 1,5-anhydroglucitol Levels in Patients with Acute Myocardial Infarction.Rev Cardiovasc Med. 2022 Dec 2;23(12):394. doi: 10.31083/j.rcm2312394. eCollection 2022 Dec. Rev Cardiovasc Med. 2022. PMID: 39076658 Free PMC article.
-
Association between baseline smoking status and clinical outcomes following myocardial infarction.Front Cardiovasc Med. 2022 Jul 22;9:918033. doi: 10.3389/fcvm.2022.918033. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35935630 Free PMC article.
-
Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.Int J Cardiol. 2013 Sep 30;168(2):1028-33. doi: 10.1016/j.ijcard.2012.10.030. Epub 2012 Nov 17. Int J Cardiol. 2013. PMID: 23164591 Clinical Trial.
-
Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.Curr Probl Cardiol. 2022 Nov;47(11):101086. doi: 10.1016/j.cpcardiol.2021.101086. Epub 2021 Dec 20. Curr Probl Cardiol. 2022. PMID: 34936910 Review.
Cited by
-
Multimorbidity in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.JACC Adv. 2025 Jul 22;4(8):102006. doi: 10.1016/j.jacadv.2025.102006. Online ahead of print. JACC Adv. 2025. PMID: 40700990 Free PMC article.
References
-
- Jagannathan R, Patel SA, Ali MK, Narayan KMV. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diab Rep. 2019;19:44. - PubMed
-
- Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–1423. Erratum in: J Am Coll Cardiol 2012;59:1663. - PMC - PubMed
-
- Gili M, Sala J, López J, Carrión A, Béjar L, Moreno J, et al. [Impact of comorbidities on in-hospital mortality from acute myocardial infarction, 2003-2009] Rev Esp Cardiol. 2011;64:1130–1137. Spanish. - PubMed
-
- Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–S29. - PubMed
LinkOut - more resources
Full Text Sources